FILE:SYK/SYK-8K-20030416160241.txt.gz
EVENTS:	Changes in control of registrant
TEXT:
ITEM: Changes in control of registrant
 
 
 
 
 
 
 
 
 
Stryker Corporation issued a press release on April 16, 2003 announcing its first quarter 2003 operating results.  A copy of this press release is attached hereto as Exhibit 99.1.  This information is being provided pursuant to Item 12 (Results of Operations and Financial Condition).
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 

 
Exhibit 99.1
 
Kalamazoo, Michigan -- April 16, 2003 - -- Stryker Corporation (NYSE:  SYK) reported today that net sales were $846.9 million for the first quarter of 2003, representing a 20% increase over net sales of $702.9 million in the first quarter of 2002.  Excluding the impact of foreign currency, net sales increased 15% for the first quarter.
Net earnings for the first quarter of 2003 were $104.1 million, representing a 28% increase over net earnings of $81.1 million in the first quarter of 2002.  Diluted net earnings per share for the quarter increased 28% to $.51 compared to $.40 in the first quarter of 2002. 
Domestic sales of $546.2 million increased 17% in the first quarter as a result of strong shipments of Orthopaedic Implants and MedSurg Equipment and higher revenue from Physical Therapy Services. 
International sales of $300.7 million increased 27% in the first quarter as a result of higher shipments of Orthopaedic Implants and MedSurg Equipment.  The impact of foreign currency comparisons to the dollar value of international sales was favorable by $36.7 million in the quarter.  Excluding the impact of foreign currency, international sales increased 11% in the quarter.
Worldwide sales of Orthopaedic Implants of $490.8 million increased 24% in the first quarter based on higher shipments of reconstructive (hip, knee and shoulder), trauma and spinal implants.  Excluding the impact of foreign currency, sales of Orthopaedic Implants increased 17% in the quarter. 
Worldwide sales of MedSurg Equipment of $304.1 million increased 18% in the first quarter based on higher shipments of powered surgical instruments, endoscopic systems, hospital beds and stretchers and craniomaxillofacial implants. Excluding the impact of foreign currency, sales of MedSurg Equipment increased 14% in the quarter.
Physical Therapy Services revenues of $52.0 million increased 5% in the first quarter as a result of new physical therapy centers.
The Company's effective income tax rate for the first quarter of 2003 was reduced to 31.0% as compared to a 33.0% effective income tax rate for the first quarter of 2002 and an effective annual income tax rate of 31.8% for the year ended December 31, 2002.  The income tax rate reduction results primarily from increased manufacturing in lower tax jurisdictions.
As previously announced, the Company will conduct a conference call for financial analysts at 5:00 p.m. Eastern Time, today.  To hear the conference call, dial 888/391-0099.  A simultaneous webcast of the call may be accessed via the Company's website at www.strykercorp.com .  The call will be archived on this website for 90 days.  A recording of the call may also be accessed from 7:00 p.m., Eastern Time, today until 7:00 p.m. on April 18, 2003 by calling 800/633-8284 (domestic) or 402/977-9140 (international) and entering the reservation number 21136103.
 
Stryker Corporation develops, manufactures and markets specialty surgical and medical products worldwide, including reconstructive implants, spinal, trauma and craniomaxillofacial systems, the bone growth factor osteogenic protein-1, powered surgical instruments, endoscopic and surgical navigation systems and patient care and handling equipment and provides outpatient physical therapy services in the United States. 
 
 
 
 
Contact Information:
Dean H. Bergy, Vice President, Chief Financial Officer and Secretary, (269) 385-2600
 


